TrialNephron2020

Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study.

Adrian C Covic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.